← FDA Drug Approvals (Drugs@FDA)
VIVJOA
NDA · New Drug Application · Sponsor: MYCOVIA PHARMS · Approved 2022-04-26
Drug application
- FDA Application #
NDA215888- Application type
- New Drug Application
- Brand name
- VIVJOA
- Generic name
- OTESECONAZOLE
- Active ingredients
- OTESECONAZOLE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MYCOVIA PHARMS
- Manufacturer
- Mycovia Pharmaceuticals, Inc.
- First approval
- 2022-04-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown